...
CVSLARGE

CVS Health Corporation

HealthcareMedical - Healthcare Plans
$79.90
$0.02(+2.42%)
52W$58.35
$85.15
FinancialsValuationvs UNH
Updated Feb 28, 12:00 AM
RSI52
RS Rating58/99
Beta0.27
Volatility30%
F-Score5/9
Mkt Cap$101.6B
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

CVS Health Corporation is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 58), indicating performance broadly in line with the market. Earnings growth of 77% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.

Relative Strength
58
out of 99
Average
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
0.27
vs S&P 500
LOW VOL
52W Position
80%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$78.46
50 SMA > 100 SMA$78.75
100 SMA > 150 SMA$76.09
150 SMA > 200 SMA$73.16

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$76.91+3.89%ABOVE
50 SMA$78.46+1.84%ABOVE
100 SMA$78.75+1.47%ABOVE
150 SMA$76.09+5.01%ABOVE
200 SMA$73.16+9.21%ABOVE

Price Performance

1D+2.4%
1W+3.8%
1M+7.9%
3M-0.6%
6M+10.8%
YTD-0.3%
1Y+21.6%
3Y-1.5%
52-Week Trading Range80% from low
$79.90
52W Low$58.35
52W High$85.15

Technical Indicators

RSI (14)NEUTRAL
51.6
305070
VCP ScoreWARM
6/10
Base depth: 16.7%

Risk Profile

Beta
0.27
52W Vol
30%
ATR
$2.57
Max DD (1Y)
-16%

Volume Analysis

Today
79
50D Avg
7.26M
Vol Ratio
0.00x
Liquidity
LIQUID

Earnings Momentum

Q1'25+60%
$1.41
Q2'25-43%
$0.80
Q3'25-4630%
$-3.13
Q4'25+77%
$2.30
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+10.12%
5 Years:+8.39%
3 Years:+7.63%
TTM:+7.85%

Compounded Profit Growth

10 Years:-11.34%
5 Years:-23.94%
3 Years:-24.73%
TTM:-62.29%

Stock Price CAGR

10 Years:-1.94%
5 Years:+2.89%
3 Years:-1.47%
1 Year:+21.58%

Return on Equity

10Y Avg:8.9%
5Y Avg:7.3%
3Y Avg:6.5%
Last Year:2.3%

Key Metrics

Market Cap$101.6B
Gross Margin13.8%
Net Margin0.4%
Piotroski F-Score5/9

More CVS Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

CVS vs UNHUNHCI

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 58 meansCVS outperformed 58% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.27 means 73% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 5/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 6/10 with WARM status.

Frequently Asked Questions

Is CVS in an uptrend right now?

CVS has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is CVS overbought or oversold?

CVS's RSI (14) is 52. The stock is in neutral territory, neither overbought nor oversold.

Is CVS outperforming the market?

CVS has a Relative Strength (RS) Rating of 58 out of 99. CVS is performing about average compared to the market.

Where is CVS in its 52-week range?

CVS is trading at $79.90, which is 94% of its 52-week high ($85.15) and 80% above its 52-week low ($58.35).

How volatile is CVS?

CVS has a Beta of 0.27 and 52-week volatility of 30%. It's less volatile than the S&P 500 - generally more stable.